146 related articles for article (PubMed ID: 3583394)
1. Carcinogenicity of anticancer drugs and especially alkylating agents.
Schmähl D
IARC Sci Publ; 1986; (78):29-35. PubMed ID: 3583394
[No Abstract] [Full Text] [Related]
2. Carcinogenicity of alkylating cytostatic drugs. Proceedings of a symposium. Heidelberg, Federal Republic of Germany, 25-27 November 1985.
IARC Sci Publ; 1986; (78):1-338. PubMed ID: 3583383
[No Abstract] [Full Text] [Related]
3. Structure-activity relationships in the carcinogenicity of anticancer agents.
Prejean JD; Montgomery JA
Drug Metab Rev; 1984; 15(3):619-46. PubMed ID: 6386411
[No Abstract] [Full Text] [Related]
4. [Carcinogenicity of anticancer agents].
Hayashi Y; Takahashi M; Yoshimura H
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2293-8. PubMed ID: 2260866
[TBL] [Abstract][Full Text] [Related]
5. [Side-effects of cytostatic therapy with special reference to potential carcinogenic effects].
Schmähl D
Internist (Berl); 1971; 12():Suppl 1:115-9. PubMed ID: 5002614
[No Abstract] [Full Text] [Related]
6. [Carcinogenic effects of antineoplastic and immunosuppressive agents].
Brock N; Schneider H
Arzneimittelforschung; 1971 Sep; 21(9):1406-10. PubMed ID: 5171799
[No Abstract] [Full Text] [Related]
7. Malignancies induced by drug therapy: a review.
Penn I
IARC Sci Publ; 1986; (78):13-27. PubMed ID: 3294589
[No Abstract] [Full Text] [Related]
8. Second neoplasm--a complication of cancer chemotherapy.
Chabner BA
N Engl J Med; 1977 Jul; 297(4):213-5. PubMed ID: 876277
[No Abstract] [Full Text] [Related]
9. Carcinogenic action of anticancer drugs with special reference to immunosuppression.
Schmähl D
Cancer; 1977 Oct; 40(4 Suppl):1927-9. PubMed ID: 332335
[TBL] [Abstract][Full Text] [Related]
10. The risk of adjuvant chemotherapy.
Gürtler R
Arch Geschwulstforsch; 1978; 48(7):644-52. PubMed ID: 736745
[No Abstract] [Full Text] [Related]
11. Experimental carcinogenesis of antitumour drugs.
Schmähl D; Habs M
Cancer Treat Rev; 1978 Dec; 5(4):175-84. PubMed ID: 104790
[No Abstract] [Full Text] [Related]
12. [The cancerogenicity of antineoplastic agents].
Rieche K
Arch Geschwulstforsch; 1969; 34(2):240-54. PubMed ID: 4920118
[No Abstract] [Full Text] [Related]
13. Use of anticancer drugs during pregnancy.
Stutzman L; Sokal JE
Clin Obstet Gynecol; 1968 Jun; 11(2):416-27. PubMed ID: 4879373
[No Abstract] [Full Text] [Related]
14. The carcinogenicity of anticancer drugs: a hazard in man.
Harris CC
Cancer; 1976 Feb; 37(2 Suppl):1014-23. PubMed ID: 766951
[TBL] [Abstract][Full Text] [Related]
15. [On ways of reducing the toxic effects of antitumorous preparations].
Monakhov BV
Vopr Onkol; 1968; 14(8):101-12. PubMed ID: 4301862
[No Abstract] [Full Text] [Related]
16. Pharmaceutics: lung toxicity of anticancer drugs.
Reich SD
Cancer Nurs; 1981 Feb; 4(1):59-60. PubMed ID: 6162538
[No Abstract] [Full Text] [Related]
17. [Experimental studies on the carcinogenic effects of anticancer chemotherapeutics and immunosuppressive agents].
Schmähl D; Osswald H
Arzneimittelforschung; 1970 Oct; 20(10):1461-7. PubMed ID: 5536412
[No Abstract] [Full Text] [Related]
18. Antitumor drug toxicity: implications for response and for survival.
Nahhas WA; Hall TC; Sherman CD; Savlov ED
Am J Med Sci; 1969 Oct; 258(4):245-59. PubMed ID: 5823461
[No Abstract] [Full Text] [Related]
19. [Strategies for studies on mechanism of action of antineoplastic agents].
Kuśnierczyk H
Postepy Hig Med Dosw; 1995; 49(1):85-96. PubMed ID: 8657622
[TBL] [Abstract][Full Text] [Related]
20. Models of normal tissue injury following combined modality therapy.
Howes AE
NCI Monogr; 1988; (6):5-8. PubMed ID: 3352789
[No Abstract] [Full Text] [Related]
[Next] [New Search]
